{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:56:21Z","timestamp":1771329381512,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019163","name":"Sociedad Espa\u00f1ola de Farmacia Familiar y Comunitaria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019163","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.rcsop.2025.100666","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T19:23:23Z","timestamp":1759346603000},"page":"100666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Risk perception, attitudes, and quality of life in a multicomponent benzodiazepine deprescription strategy"],"prefix":"10.1016","volume":"20","author":[{"given":"Ingrid","family":"Ferrer L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Olry de Labry-Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Guti\u00e9rrez-Valencia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Encarnaci\u00f3n","family":"Garc\u00eda Berm\u00fadez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Atienza Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalia Garc\u00eda-Delgado","family":"Morente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Dolores","family":"Murillo Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"S\u00e1nchez Ca\u00f1ete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Berm\u00fadez-Tamayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcsop.2025.100666_bb0005","series-title":"Benzodiazepines. In Treasure Island (FL)","author":"Bounds","year":"2024"},{"issue":"5","key":"10.1016\/j.rcsop.2025.100666_bb0010","doi-asserted-by":"crossref","first-page":"152","DOI":"10.18773\/austprescr.2015.055","article-title":"Management of benzodiazepine misuse and dependence","volume":"38","author":"Brett","year":"2015","journal-title":"Aust Prescr"},{"issue":"680","key":"10.1016\/j.rcsop.2025.100666_bb0015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3399\/bjgp19X701753","article-title":"Prescribing benzodiazepines in general practice","volume":"69","author":"Kennedy","year":"2019","journal-title":"Br J Gen Pract"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100666_bb0020","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-024-05027-9","article-title":"Barriers, facilitators and needs to deprescribe benzodiazepines and other sedatives in older adults: a mixed methods study of primary care provider perspectives","volume":"24","author":"H\u00fcrlimann","year":"2024","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.rcsop.2025.100666_bb0025","series-title":"Facts and figures on benzodiazepines and other benzodiazepines anxiolytics and hypnosedatives","author":"Ministry of Health","year":"2024"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100666_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-020-08984-z","article-title":"Trends in the consumption rates of benzodiazepines and benzodiazepine-related drugs in the health region of Lleida from 2002 to 2015","volume":"20","author":"Torres-Bondia","year":"2020","journal-title":"BMC Public Health"},{"key":"10.1016\/j.rcsop.2025.100666_bb0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.socscimed.2017.01.020","article-title":"\u201cToo much medicine\u201d: insights and explanations from economic theory and research","volume":"176","author":"Hensher","year":"2017","journal-title":"Soc Sci Med"},{"issue":"5","key":"10.1016\/j.rcsop.2025.100666_bb0040","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/00048674231223690","article-title":"What set some young adults apart during the COVID-19 pandemic? Mental health trajectories, risk and protective factors in an Australian longitudinal study","volume":"58","author":"Donohoe-Bales","year":"2024","journal-title":"Aust N Z J Psychiatry"},{"issue":"4","key":"10.1016\/j.rcsop.2025.100666_bb0045","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/jgs.18728","article-title":"Evaluation of a benzodiazepine deprescribing quality improvement initiative for older adults in primary care","volume":"72","author":"Chae","year":"2024","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.rcsop.2025.100666_bb0050","series-title":"A Toolkit for Reducing Inappropriate Use of Benzodiazepines and Sedative-Hypnotics among Older Adults in Primary Care. Ontario","author":"Choosing Wisely","year":"2023"},{"key":"10.1016\/j.rcsop.2025.100666_bb0055","series-title":"Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults NICE guideline","year":"2022"},{"key":"10.1016\/j.rcsop.2025.100666_bb0060","series-title":"Do not administer long-acting benzodiazepines for the chronic treatment of insomnia in individuals over 65 years of age","author":"Guiasalud","year":"2025"},{"issue":"2","key":"10.1016\/j.rcsop.2025.100666_bb0065","doi-asserted-by":"crossref","DOI":"10.23938\/ASSN.1005","article-title":"Identifying barriers and enablers for benzodiazepine (de)prescription: a qualitative study with patients and healthcare professionals","volume":"45","author":"Marquina-M\u00e1rquez","year":"2022","journal-title":"An Sist Sanit Navar"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100666_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40271-016-0182-z","article-title":"A systematic review and Meta-synthesis of patients\u2019 experiences and perceptions of seeking and using benzodiazepines and Z-drugs: towards safer prescribing","volume":"10","author":"Sirdifield","year":"2017","journal-title":"Patient"},{"key":"10.1016\/j.rcsop.2025.100666_bb0075","series-title":"Deprescribing medications: barriers and enablers","author":"Mackey","year":"2020"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100666_bb0080","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pec.2013.02.016","article-title":"A drug education tool developed for older adults changes knowledge, beliefs and risk perceptions about inappropriate benzodiazepine prescriptions in the elderly","volume":"92","author":"Martin","year":"2013","journal-title":"Patient Educ Couns."},{"key":"10.1016\/j.rcsop.2025.100666_bb0085","first-page":"346","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","author":"Chan","year":"2013","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.rcsop.2025.100666_bb0090","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1192\/bjp.bp.113.134650","article-title":"Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: cluster randomised controlled trial in primary care","volume":"204","author":"Vicens","year":"2014","journal-title":"Br J Psychiatry"},{"issue":"6","key":"10.1016\/j.rcsop.2025.100666_bb0095","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2014.949","article-title":"Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial","volume":"174","author":"Tannenbaum","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"18","key":"10.1016\/j.rcsop.2025.100666_bb0100","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.16131","article-title":"Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE randomized clinical trial","volume":"320","author":"Martin","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100666_bb0105","doi-asserted-by":"crossref","DOI":"10.1186\/s12875-022-01952-z","article-title":"The effectiveness and cost of integrating pharmacists within general practice to optimize prescribing and health outcomes in primary care patients with polypharmacy: a systematic review","volume":"24","author":"Croke","year":"2023","journal-title":"BMC Prim Care"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100666_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s13012-022-01247-y","article-title":"Strategies for de-implementation of low-value care\u2014a scoping review","volume":"17","author":"Ingvarsson","year":"2022","journal-title":"Implement Sci"},{"issue":"4","key":"10.1016\/j.rcsop.2025.100666_bb0115","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.gaceta.2018.11.005","article-title":"Deimplementation of low-value clinical activities. From the evidence, through consensus, to a change in practices","volume":"33","author":"Berm\u00fadez-Tamayo","year":"2019","journal-title":"Gac Sanit"},{"issue":"590","key":"10.1016\/j.rcsop.2025.100666_bb0120","doi-asserted-by":"crossref","DOI":"10.3399\/bjgp11X593857","article-title":"Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis","volume":"61","author":"Mugunthan","year":"2011","journal-title":"Br J Gen Pract"},{"issue":"8","key":"10.1016\/j.rcsop.2025.100666_bb0125","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.sapharm.2025.03.063","article-title":"Effectiveness at long-term of a multidisciplinary intervention in the reduction of overuse of benzodiazepine prescriptions: a cluster controlled trial","volume":"21","author":"L\u00f3pez","year":"2025","journal-title":"Res Social Adm Pharm."},{"issue":"1","key":"10.1016\/j.rcsop.2025.100666_bb0130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1745-6215-14-80","article-title":"An educational intervention to reduce the use of potentially inappropriate medications among older adults (EMPOWER study): protocol for a cluster randomized trial","volume":"14","author":"Martin","year":"2013","journal-title":"Trials"},{"issue":"6","key":"10.1016\/j.rcsop.2025.100666_bb0135","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0212-6567(02)70587-8","article-title":"La evaluaci\u00f3n de la calidad de vida relacionada con la salud en la consulta: Las vi\u00f1etas COOP\/WONCA","volume":"29","author":"Liz\u00e1n Tudela","year":"2002","journal-title":"Aten Primaria"},{"issue":"5","key":"10.1016\/j.rcsop.2025.100666_bb0140","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100666_bb0145","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12875-020-01166-1","article-title":"Evidence for deprescription in primary care through an umbrella review","volume":"21","author":"de Labry","year":"2020","journal-title":"BMC Fam Pract"},{"issue":"3","key":"10.1016\/j.rcsop.2025.100666_bb0150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/fampra\/cmq113","article-title":"Discontinuation of long-term benzodiazepine use: 10-year follow-up","volume":"28","author":"de Gier","year":"2011","journal-title":"Fam Pract"},{"issue":"12","key":"10.1016\/j.rcsop.2025.100666_bb0155","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/jamapsychiatry.2024.2731","article-title":"Patient self-guided interventions to reduce sedative use and improve sleep: the YAWNS NB randomized clinical trial","volume":"81","author":"Gardner","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100666_bb0160","doi-asserted-by":"crossref","DOI":"10.1186\/s12875-022-01655-5","article-title":"Direct-to-consumer strategies to promote deprescribing in primary care: a pilot study","volume":"23","author":"Linsky","year":"2022","journal-title":"BMC Prim Care"},{"issue":"11","key":"10.1016\/j.rcsop.2025.100666_bb0165","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.mayocp.2016.07.024","article-title":"Benzodiazepine use in older adults: dangers, management, and alternative therapies","volume":"91","author":"Markota","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.rcsop.2025.100666_bb0170","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-015959","article-title":"A realist evaluation of patients\u2019 decisions to deprescribe in the EMPOWER trial","volume":"7","author":"Martin","year":"2017","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.rcsop.2025.100666_bb0175","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/10600280211033022","article-title":"Addressing barriers to reducing prescribing and implementing deprescribing of sedative-hypnotics in primary care","volume":"56","author":"Burry","year":"2022","journal-title":"Ann Pharmacother"},{"issue":"11","key":"10.1016\/j.rcsop.2025.100666_bb0180","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.sapharm.2018.12.007","article-title":"Benzodiazepine use risk: understanding patient specific risk perceptions and medication beliefs","volume":"15","author":"Sake","year":"2019","journal-title":"Res Social Adm Pharm"},{"issue":"5","key":"10.1016\/j.rcsop.2025.100666_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.116","article-title":"Benzodiazepine usage and patient preference for alternative therapies: a descriptive study","volume":"2","author":"Sake","year":"2019","journal-title":"Health Sci Rep"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100666_bb0190","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pec.2013.02.016","article-title":"A drug education tool developed for older adults changes knowledge, beliefs and risk perceptions about inappropriate benzodiazepine prescriptions in the elderly","volume":"92","author":"Martin","year":"2013","journal-title":"Patient Educ Couns"},{"issue":"8","key":"10.1016\/j.rcsop.2025.100666_bb0195","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00228-017-2257-8","article-title":"A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people","volume":"73","author":"Reeve","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.rcsop.2025.100666_bb0200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/pcn.13195","article-title":"Does cognitive behavioral therapy for anxiety disorders assist the discontinuation of benzodiazepines among patients with anxiety disorders? A systematic review and meta-analysis","volume":"75","author":"Takeshima","year":"2021","journal-title":"Psychiatry Clin Neurosci"},{"issue":"5","key":"10.1016\/j.rcsop.2025.100666_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003983","article-title":"Evaluation of a multicomponent intervention consisting of education and feedback to reduce benzodiazepine prescriptions by general practitioners: the BENZORED hybrid type 1 cluster randomized controlled trial","volume":"19","author":"Vicens","year":"2022","journal-title":"PLoS Med"},{"issue":"15","key":"10.1016\/j.rcsop.2025.100666_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18157964","article-title":"Evaluating the implementation of a multicomponent intervention consisting of education and feedback on reducing benzodiazepine prescriptions by general practitioners: Benzored hybrid type i cluster randomized controlled trial","volume":"18","author":"Socias","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"10.1016\/j.rcsop.2025.100666_bb0215","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/13607860410001669778","article-title":"Attitudes to long-term use of benzodiazepine hypnotics by older people in general practice: findings from interviews with service users and providers","volume":"8","author":"Iliffe","year":"2004","journal-title":"Aging Ment Health"},{"issue":"5","key":"10.1016\/j.rcsop.2025.100666_bb0220","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/13561820.2021.1973975","article-title":"A systematic meta-review of systematic reviews about interprofessional collaboration: facilitators, barriers, and outcomes","volume":"36","author":"Wei","year":"2022","journal-title":"J Interprof Care"},{"key":"10.1016\/j.rcsop.2025.100666_bb0225","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s13104-016-2103-6","article-title":"A survey of primary care patients\u2019 readiness to engage in the de-adoption practices recommended by choosing Wisely Canada","volume":"9","author":"Silverstein","year":"2016","journal-title":"BMC Res Notes"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276625001076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276625001076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T12:50:11Z","timestamp":1764766211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276625001076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":45,"alternative-id":["S2667276625001076"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2025.100666","relation":{},"ISSN":["2667-2766"],"issn-type":[{"value":"2667-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk perception, attitudes, and quality of life in a multicomponent benzodiazepine deprescription strategy","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2025.100666","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100666"}}